🔴 Echo IQ is trading 7.75% down with no clear company-specific catalyst

Echo IQ is trading 7.75% down at A$0.66, with no clear company-specific announcement identified for September 23, 2026.

• The latest material disclosure was the September 17 update outlining an FDA appeal, Ombudsman review, or new 510(k) pathway following the EchoSolv HF determination; it preceded the current decline.
• The broader market was broadly flat, offering no strong global explanation.